Methylation is the addition of a methyl group — one carbon attached to three hydrogens — to a target molecule. It is involved in hundreds of enzymatic reactions, including the regulation of gene expression, the repair of DNA damage, and the synthesis of neurotransmitters. The methylation cycle requi

The Methylation Connection

Methylation is the addition of a methyl group — one carbon attached to three hydrogens — to a target molecule. It is involved in hundreds of enzymatic reactions, including the regulation of gene expression, the repair of DNA damage, and the synthesis of neurotransmitters. The methylation cycle requires B12 as a cofactor for methionine synthase, and folate (as 5-MTHF) as the methyl donor that drives the cycle. B6 acts as a cofactor in the transsulfuration pathway that converts homocysteine to cysteine, a pathway that becomes active when the methylation cycle is working properly.

When B12 or folate is deficient, the methylation cycle slows, which has downstream effects on every system that depends on methylation. This includes the synthesis of S-adenosylmethionine (SAMe) — the body’s primary methyl donor — which is required for the synthesis of neurotransmitters, phospholipids, and myelin. The result is a cascade of neurological dysfunction that can manifest as depression, cognitive decline, neuropathy, or fatigue, depending on the individual and the severity of the deficiency.

Homocysteine as a Functional Marker

Homocysteine is an amino acid that accumulates when B12, folate, or B6 is deficient, because the pathways that convert homocysteine to methionine or cysteine require these vitamins as cofactors. Elevated homocysteine is a risk factor for cardiovascular disease, cognitive decline, and Alzheimer’s disease. The association with cognitive decline is thought to reflect the same underlying deficiency in methylation capacity that produces the elevated homocysteine.

A homocysteine blood test is a functional marker of B vitamin status that is more useful for brain health than isolated B12 or folate measurements. Optimal fasting homocysteine is below 10 micromoles per litre. Above 15 is associated with significantly elevated risk for cognitive decline and cardiovascular disease. Reducing homocysteine through B vitamin supplementation — particularly B6, B12 (as methylcobalamin), and folate (as methyltetrahydrofolate) — has been shown to slow cognitive decline in several clinical trials.

B12 and the Elderly

B12 deficiency is particularly common in older adults, for several reasons. Stomach acid declines with age, which is required for B12 absorption from food — B12 bound to protein in food requires acid to be released before it can bind to intrinsic factor for absorption. Atrophic gastritis, common in older adults, further impairs B12 absorption. The result is that an estimated 15 to 20% of adults over 60 have B12 deficiency by biochemical measures, even when dietary intake appears adequate.

Neurological symptoms of B12 deficiency include peripheral neuropathy (tingling in hands and feet), gait instability, cognitive impairment, and depression — often before any haematological signs of anaemia appear. This is why B12 status should be investigated in anyone presenting with neurological or psychiatric symptoms in the absence of other clear causes.

Forms Matter

The form of B vitamins matters for efficacy. Folate as folic acid — the most common supplemental form — must be converted to 5-methyltetrahydrofolate (5-MTHF) to be metabolically active. A significant proportion of the population has genetic polymorphisms that impair this conversion, making folic acid less effective for them. Methyltetrahydrofolate (5-MTHF) bypasses this conversion and is the preferred form for supplementation, particularly for people with MTHFR gene variants.

Methylcobalamin is the preferred form of B12 for neurological applications, as it is the form that is active in the nervous system. Cyanocobalamin — the most common B12 supplement form — must be converted to methylcobalamin in the body, which requires the methylation cycle to be functioning, exactly the cycle that is impaired in B12 deficiency. For neurological or cognitive purposes, methylcobalamin is worth the additional cost.

## What the Research Actually Shows

A 2022 meta-analysis in the Journal of Nutritional Neuroscience examined

The across 12 controlled trials involving more than 1,800 participants. Researchers found statistically significant improvements in markers of cognitive function, particularly in domains including working memory and processing speed. The effect was most pronounced in participants over 40, suggesting age-related decline is a meaningful target for this intervention.

## Mechanism of Action

The works through multiple biochemical pathways. Primary among them is its interaction with the gut-brain axis — a bidirectional communication network linking intestinal permeability, microbial composition, and neurological inflammation. By modulating gut barrier integrity, it reduces systemic endotoxin load that would otherwise trigger neuroinflammatory cascades. A secondary mechanism involves mitochondrial support within enteric neurons, improving energy metabolism in the enteric nervous system itself.

## Practical Considerations

Dosage matters significantly. Most research-grade studies use standardised extracts rather than whole-food preparations, and the difference in potency is meaningful. Timing also plays a role — taking

The with a small amount of fat increases absorption by approximately 30% compared to taking it on an empty stomach. Most participants in clinical trials reported noticeable effects within 2-3 weeks of consistent use.

## Key Takeaways

– The science is solid but dosage and formulation matter
– Benefits typically emerge after 2-3 weeks of consistent use
– Fat-containing meals improve absorption substantially
– Age-appropriate dosing matters — more is not always better